RxDoctor Payments Data

Richard Nelson, PA

Physician Assistant · Asheville, NCNPI 1487736708

Payments from drug & device makers

$1,915in general payments, 2019–2025

Across 69 payments — averaging $27.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$554
  • AbbVie$518
  • Takeda Pharmaceuticals U.S.A., Inc.$208
  • Ironwood Pharmaceuticals, Inc$155
  • Johnson & Johnson$113
  • Ardelyx, Inc.$89
  • plus $277 from 8 others

What the payments were for

  • Travel & lodging$55429%
  • Food & beverage$1,36171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,915 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$33,928
Medicare patients
235
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin26$77,811
LinzessLinaclotide70$65,768
MotegrityPrucalopride Succinate19$16,313
Mesalamine34$7,947
Dexlansoprazole DrDexlansoprazole12$3,127
Balsalazide Disodium21$3,058
Mesalamine ErMesalamine13$2,636
Lubiprostone11$2,563
Famotidine152$2,548
Budesonide EcBudesonide19$2,164
Omeprazole184$1,986
Pantoprazole Sodium105$1,199
Lactulose11$1,181
Dicyclomine Hcl74$1,175
Lansoprazole11$888

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$20$77,81126 claims
AbbVieLinzess$518$65,76870 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$208$16,31319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →